View the content of this email online

A new GMP offer for lentiviral vectors

GMP dyptique
Flash Therapeutics opens a GMP facility to produce lentiviral vector batches for customers conducting phase I/II gene therapy clinical trials.

A fully integrated & flexible GMP vector offer:

  1. Expertise in lentiviral vector process development and manufacturing since 2005 (+6000 R&D batches delivered)
  2. Highly concentrated and purified lentiviral vectors
  3. A premium and scalable production process
  4. Full GMP project management

To learn more about our GMP offer

Click Here

Follow us

Twitter Flash Therapeutics LinkedIn Flash Therapeutics Youtube Flash Therapeutics Google + Flash Therapeutics
© Flash Therapeutics 2018

Click here to unsuscribe from the mailing list